Full View

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway

A Shatanawi, MJ Romero, JA Iddings… - … of Physiology-Cell …, 2011 - journals.physiology.org
Enhanced vascular arginase activity impairs endothelium-dependent vasorelaxation by
decreasing l-arginine availability to endothelial nitric oxide (NO) synthase, thereby reducing …
被引用次数：170 相关文章

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway

A Shatanawi, MJ Romero… - … of Physiology-Cell …, 2011 - augusta.elsevierpure.com
Enhanced vascular arginase activity impairs endothelium-dependent vasorelaxation by
decreasing Larginine availability to endothelial nitric oxide (NO) synthase, thereby reducing …

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.

A Shatanawi, MJ Romero, JA Iddings… - American Journal of …, 2011 - europepmc.org
Enhanced vascular arginase activity impairs endothelium-dependent vasorelaxation by
decreasing l-arginine availability to endothelial nitric oxide (NO) synthase, thereby reducing …
[PDF] researchgate.net

[PDF][PDF] Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway

A Shatanawi, MJ Romero, JA Iddings… - Am J Physiol Cell …, 2011 - researchgate.net
Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38
mitogen-activated protein kinase/arginase pa Page 1 Angiotensin II-induced vascular …
[HTML] nih.gov

[HTML][HTML] Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway

A Shatanawi, MJ Romero, JA Iddings… - American Journal of …, 2011 - ncbi.nlm.nih.gov
Enhanced vascular arginase activity impairs endothelium-dependent vasorelaxation by
decreasing l-arginine availability to endothelial nitric oxide (NO) synthase, thereby reducing …

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway

A Shatanawi, MJ Romero, JA Iddings… - American Journal of …, 2011 - cir.nii.ac.jp
抄録< jats: p> Enhanced vascular arginase activity impairs endothelium-dependent
vasorelaxation by decreasing l-arginine availability to endothelial nitric oxide (NO) synthase …

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway

A Shatanawi, MJ Romero, JA Iddings… - American Journal of …, 2011 - experts.nebraska.edu
Enhanced vascular arginase activity impairs endothelium-dependent vasorelaxation by
decreasing Larginine availability to endothelial nitric oxide (NO) synthase, thereby reducing …

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway

A Shatanawi, MJ Romero, JA Iddings… - … of physiology. Cell …, 2011 - pubmed.ncbi.nlm.nih.gov
Enhanced vascular arginase activity impairs endothelium-dependent vasorelaxation by
decreasing l-arginine availability to endothelial nitric oxide (NO) synthase, thereby reducing …

Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.

A Shatanawi, MJ Romero, JA Iddings… - American Journal of …, 2011 - europepmc.org
Enhanced vascular arginase activity impairs endothelium-dependent vasorelaxation by
decreasing l-arginine availability to endothelial nitric oxide (NO) synthase, thereby reducing …

[引用][C] Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway

A SHATANAWI, MJ ROMERO… - American …, 2011 - American Physiological Society